1,929 reports of this reaction
1.8% of all APIXABAN reports
#10 most reported adverse reaction
DIZZINESS is the #10 most commonly reported adverse reaction for APIXABAN, manufactured by Amneal Pharmaceuticals of New York LLC. There are 1,929 FDA adverse event reports linking APIXABAN to DIZZINESS. This represents approximately 1.8% of all 106,298 adverse event reports for this drug.
Patients taking APIXABAN who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for APIXABAN, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for APIXABAN:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 1,929 FDA reports for APIXABAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 1.8% of all adverse event reports for APIXABAN, making it a notable side effect.
If you experience dizziness while taking APIXABAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.